Nogo-A Mediated Endoplasmic Reticulum Stress During Myocardial Ischemic-Reperfusion Injury in Diabetic Rats
Authors (first, second and last of 8)

Cardiovascular Toxicology is the only journal dedicated to publishing contemporary issues, timely reviews, and experimental and clinical data on the molecular therapy of cardiovascular disease. CT publishes papers that will elucidate the effects, molecular mechanisms, and signaling pathways of environmental toxicants on the cardiovascular system. Also covered are the detrimental effects of new cardiovascular drugs, and cardiovascular effects of non-cardiovascular drugs, anti-cancer chemotherapy, and gene therapy. In addition, Cardiovascular Toxicology reports safety and toxicological data on new cardiovascular and non-cardiovascular drugs. This is a unique journal in which these data can be scrutinized separately from efficacy.
Cardiovascular Toxicology was launched in 2001, and has been produced regularly for 20 years. It started 4 issues/year until 2018, expanding to 6 issues/year. It is now ready to expand again to 12 issues/year starting 2021.
Avoid the most common mistakes and prepare your manuscript for journal editors.
Learn more© Springer Science+Business Media, LLC, part of Springer Nature